Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Curaleaf Holdings Inc
(OP:
CURLF
)
3.060
+0.030 (+0.99%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Curaleaf Holdings Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
48
49
Next >
Largest Cannabis MSO Stocks Advanced 8.5%, On Average, Last Week
March 24, 2024
The legalization of cannabis in Germany last week sparked a 66% surge in the 5 largest Canadian cannabis LP stocks last week but only a 8.5% increase in the 7 largest American cannabis MSO stocks.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Set To Dominate Germany's New Market: A Surge In Demand Meets Established Expertise
March 22, 2024
Germany's historic step towards cannabis legalization, effective April 1, 2024, opens a new chapter in the global cannabis industry, presenting substantial opportunities for Canadian leaders Aurora...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Is Now A Good Time To Buy NewLake Capital Partners?
March 21, 2024
Via
Benzinga
7 Growth Stocks That Could Turn $10,000 into $70,000 by 2028
March 21, 2024
These are the attractively valued growth stocks to buy as they represent companies positioned for robust growth and EBITDA margin expansion
Via
InvestorPlace
Wall Street’s Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich
March 20, 2024
Recent news has investors more interested in Wall Street’s favorite cannabis stocks. Here are three momentum plays.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Could Get a Lift From an Unexpected Catalyst Later This Year
March 20, 2024
Valuations are low in the cannabis industry, and now may be an opportune time for long-term investors to buy pot stocks.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
3 OTC Stocks With the Potential to Deliver Multibagger Paydays by 2026
March 20, 2024
These are the undervalued OTC stocks to buy as they represent companies with good fundamentals and prospects of free cash flow upside.
Via
InvestorPlace
US At Cannabis Crossroads: VP Harris Urges DEA Action, Where Do Industry Leaders Stand?
March 19, 2024
Vice President Kamala Harris is urging the DEA to accelerate the process of rescheduling marijuana under the Controlled Substances Act.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Curaleaf Strengthens Presence In Germany Via New Cannabis Acquisition
March 19, 2024
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) said on Tuesday that it has signed a deal to acquire Northern Green Canada. NGC is a Canadian licensed producer of cannabis, with a focus on expanding...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
420 with CNW — How Cannabis Firms Can Prepare Themselves for Future After Rescheduling
March 18, 2024
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
New York Gov Hochul Orders Review Of Cannabis Licensing Process After Numerous Setbacks
March 18, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
"Freaky Friday" Startled Our American Cannabis MSO Index, In A Good Way
March 17, 2024
Last Friday the trading volume in the 7 stocks in our American Cannabis MSO Stocks Index was 51.5% higher than the average daily trading volume. Pricewise, the Index was up almost 15%.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Jump On News That DEA May Soon Undertake Marijuana Reform
March 15, 2024
Doug Kass, world-renowned hedge fund manager, posted on X, formerly Twitter, Friday that the "DEA will approve a rescheduling of cannabis to Schedule III."
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
March 14, 2024
The European cannabis market is one of the most rapidly expanding markets globally.Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Q4 Financials Of Cannabis MSO, Curaleaf, Show Improvement Across The Board
March 14, 2024
Curaleaf management reports that the work the company has done over the past several quarters paid off in Q4, and that global opportunities are unfolding rapidly as expected.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
The 3 Most Undervalued Cannabis Stocks to Buy in March 2024
March 12, 2024
Tap into the promise of undervalued cannabis stocks as progressive legislative developments and growing support point to a robust upside.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
DEA Vs. White House: Agency Pushes Back On Medical Benefits Of Cannabis, Weed Stocks Wobble
March 11, 2024
In addition to reportedly doubting the scientific evidence presented by HHS, the DEA also expressed concern about the increasing potency of THC, the psychoactive compound in cannabis. Marijuana...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Budding Millionaires: 3 Cannabis Stocks With 5-Bagger Potential by 2025
March 11, 2024
These three cannabis stocks have the potential to skyrocket by 2025. Buy now before they start to take off.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Our 7 Largest Cannabis MSO Stocks Dropped 7.1% Last Week
March 10, 2024
Each of the 7 stocks in our American Cannabis MSO Stocks Index dropped last week, by an average of 7.1%. This brings their YTD average to +21%.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Amsterdam Not Included In Government's Legal Cannabis Trial, And More Marijuana Updates Across Europe
March 08, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Industry Responds To Biden's Historic State Of The Union Call For Cannabis Reform
March 08, 2024
President Joe Biden's historic remarks about cannabis reform in Thursday's State of the Union speech sparked widespread discussion across the industry, which many cannabis companies shared with...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From March 7, 2024
March 07, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CURLF Stock Earnings: Curaleaf Holdings Beats EPS, Beats Revenue for Q4 2023
March 06, 2024
CURLF stock results show that Curaleaf Holdings beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Curaleaf Reports Record Q4 Revenue Of $345M, Narrows Loss On Higher Sales, Growing Market Share
March 06, 2024
Curaleaf reports fourth-quarter 2023 revenue of $345 million, representing an increase of 4% quarter-over-quarter.
Via
Benzinga
Cannabis Stock Movers For March 6, 2024
March 06, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Inside Curaleaf's Growth Strategy: Boris Jordan's Vision For Cannabis Market Dominance Through Flower Quality
March 04, 2024
Boris Jordan, executive chair of Curaleaf Holdings Inc., discusses the company's commitment to improving flower quality and becoming a market leader in cannabis products. With operations in 18 states...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Largest Cannabis MSO Stocks Down 9% In February; Still Up 26% YTD
March 01, 2024
Only two of the 7 stocks in the American Cannabis MSO Stocks Index were up in February with the index going down 8.9% but remaining up 25.9% YTD.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Advocates Say Biden Missing Huge Opportunity by Not Pursuing Cannabis Legalization
March 01, 2024
Via
CannabisNewsWire
Topics
Cannabis
Law Enforcement
Exposures
Cannabis
Legal
Curaleaf Price Target Spikes, Fueled By German Cannabis Legalization Changes — ROTH MKM Explains
February 28, 2024
Strategic Outlook And Earnings Forecast
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
All You Need To Know About The German Marijuana Market: Changes, Size And Leading Players
February 28, 2024
Senior analyst Pablo Zuanic of Zuanic & Associates outlines the transformative potential of new legislation in Germany's medical cannabis sector, forecasting market growth from a 28,000 patient base in...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
48
49
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.